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Abstract
Electronic health record (EHR) systems offer an exceptional opportunity for studying many diseases and their associated
medical conditions within a population. The increasing number of clinical record entries that have become available
electronically provides access to rich, large sets of patients’ longitudinal medical information. By integrating and comparing
relations found in the EHRs with those already reported in the literature, we are able to verify existing and to identify rare or
novel associations. Of particular interest is the identification of rare disease co-morbidities, where the small numbers of
diagnosed patients make robust statistical analysis difficult. Here, we introduce ADAMS, an Application for Discovering
Disease Associations using Multiple Sources, which contains various statistical and language processing operations. We
apply ADAMS to the New York-Presbyterian Hospital’s EHR to combine the information from the relational diagnosis tables
and textual discharge summaries with those from PubMed and Wikipedia in order to investigate the co-morbidities of the
rare diseases Kaposi sarcoma, toxoplasmosis, and Kawasaki disease. In addition to finding well-known characteristics of
diseases, ADAMS can identify rare or previously unreported associations. In particular, we report a statistically significant
association between Kawasaki disease and diagnosis of autistic disorder.
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Introduction
The latter half of the twentieth century and to a greater extent
the beginning of the twenty-first century saw a prolific and rapid
expansion in the transition of clinical record systems from paper to
electronic. Health care systems stand to benefit signficantly from
the switch to electronic health record (EHR) systems as more
clinical data become more easily captured and accessed. The
complex nature of health care and of how patient information is
reported makes EHR systems extremely challenging to implement.
We are only now beginning to see their power and to learn how
they can be effectively mined for information. Governments are
pushing for the adoption of EHR systems because of their
burgeoning importance in effective care and treatment. In the
United States, for example, the 2009 American Recovery and
Reinvestment Act has allocated $19 billion to research into health
information systems [1], and in the United Kingdom, a large
project to modernise the National Health Service and to move all
patient records to a centralized database is currently underway
[2–4]. It is important to understand how the large amounts of data
being archived in these systems can be correctly and effectively
interpreted.
EHRs not only facilitate improvements in quality of care [1],
they also facilitate clinical research and epidemiological studies,
particularly as they increase the availability of patients’ medical
information [5,6]. The Rare Disease Act of 2002 defines a rare
disease as any disease or condition that affects fewer than two
hundred thousand persons in the United States [7]. Therefore, by
definition, there are a minimal number of people suffering from
any particular rare condition, making rigorous statistical analyses
of these patient cohorts complex. EHRs offer some of the most
enriched data sets available for studying rare diseases in detail, in
particular for studying associated risks to determine if there are
factors that may exacerbate conditions.
The New York-Presbyterian Hospital (NYPH) has been using
an electronic health record system for the past twenty years. Each
patient gets a descriptive, longitudinal record describing what
happened during each patient encounter. The record details
attending consultations, case histories, diagnoses, lab test results,
medications, and procedures. Therefore the EHR at NYPH has
become the de facto method for storing information about patients
and an important means of carrying out analyses of patient data.
The amount of data entered into the NYPH EHR has been
increasing at an exponential rate, with data entry doubling every
eight years (Fig. 1), making it a large and comprehensive EHR
system.
Finding information on rare diseases in the NYPH EHR is a
data mining problem. Processing several hundred million records
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NYPH EHR system can be loosely divided into two parts: one that
archives physician notes in a textual format, and one that describes
patients’ states using code descriptors in the form of proprietary
internal codes or codes from the International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).
Textual notes provide the greatest amount of information about a
patient; however, they contain natural language, which can be
ambiguous and context-based with relatively complex grammar,
thus making accurate information extraction hard. ICD-9-CM
codes, on the other hand, are easy to process, but they are not
necessarily comprehensively descriptive. Missing and incomplete
data also make discerning signal more difficult, since EHRs may not
be fully up to date, depending on the frequency of patient visits.
Textual sources can be data mined to understand whether local
EHR findings have been observed elsewhere. Journal articles can
complement EHR data for studying disease associations by
providing an aggregate of published information from around
the world. Data mining journal articles has become a feasible
method for determining relationships between concepts [8]. The
National Center for Biotechnology Information (NCBI) maintains
PubMed, an extensive Internet-based journal archive of biological
papers [9]. Data mining and natural language processing (NLP)
have previously been used to analyze journal articles [10–13].
Web sites such as Wikipedia provide another source of information
on diseases and have recently started to be data mined [14,15].
Although considered less reliable than journal sources, web sites
contain data on many subjects and serve as a proxy to summarize
multiple sources.
Previous studies have used EHR systems to research diseases;
however, they primarily use the EHR as the sole data source (for
example see [16–18]). In this paper, we present ADAMS, an
Application for the Discovery of Disease Associations using
Multiple Sources. It combines rigorous multiple hypothesis testing
and false discovery rate analysis of relational diagnosis tables and
NLP processed textual discharge summaries, in addition to the
information retrieved from PubMed and Wikipedia. We apply
ADAMS to the NYPH EHR to investigate the co-morbidities
associated with Kaposi sarcoma, toxoplasmosis, and Kawasaki
disease.
Kaposi sarcoma is a tumor caused by human herpesvirus 8, also
known as Kaposi sarcoma-associated herpesvirus [19]. The
condition came to prominence with the AIDS epidemic of the
1980’s as it was seen to be a frequent and aggressive disease in
AIDS patients. It also has been closely associated with immuno-
suppressed patients [20,21]. We chose to apply our methodology
to Kaposi sarcoma because of the high risk and important role it
plays in patients with HIV/AIDS.
Toxoplasmosis also affects immunocompromised individuals,
either through HIV infection or immunosuppressive therapy. It is
caused by the obligate intracellular parasitic protozoon toxoplasma
gondii. It was selected to study whether the signs and symptoms
from congenital infection and immunocompromise could be
identified. Furthermore, comparing Kaposi sarcoma with toxo-
plasmosis could allow for the study of ICD-9-CM codes specific to
each as opportunistic infections [22].
We also selected a rare disease for its peak incidence in a narrow
age group. Kawasaki disease, also known as mucocutaneous
lymph node syndrome, is an acute vasulitis that most commonly
occurs between one and four years of age. It is generally benign
and self-limited, although it is associated with coronary artery
aneurysms and an overall case-fatality rate of 0.5–2.8% [23–25].
Figure 1. The amount of data entered into the NYPH EHR database each year has been increasing at an exponential rate since 1990
with data entry doubling every 8 years.
doi:10.1371/journal.pone.0021132.g001
Disease Associations in Electronic Clinical Data
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e21132This disease was selected because of the predominant distribution
in children and to evaluate ADAMS’s ability to identify
predisposing risk factors and sequelae of the disease.
To account for background noise in the data, control groups
were required, for which we chose cohorts of post-traumatic stress
disorder (PTSD) patients and influenza patients. PTSD is a
psychiatric condition that can affect people who experience
traumatic events. PTSD is a fitting control disease because it is
regarded as the ‘‘common cold’’ of psychiatric disorders [26].
Exposure is common, with two-thirds of the population exposed to
a traumatic event at least once throughout their lives. Most people
who experience traumatic events will not develop PTSD, as the
lifetime prevalence of PTSD in the general population is around
7%. Half of the people who develop PTSD recover within a year
without professional help, but 15% will not recover despite
receiving treatment [27].
Influenza patients are suitable as a control cohort since
influenza is a broadly contracted infectious disease. While
influenza virus can infect individuals without causing acute
symptomatic disease, some people do suffer sufficiently acute
symptoms to visit the hospital. These people who come to the
hospital would be sicker than those who can stay home; the NYPH
EHR would have a bias toward sicker influenza patients. Since
influenza is a control, this bias would make statistically significant
case associations less likely among the ICD-9-CM codes that occur
more often among sicker influenza patients.
It is a difficult problem to define a representative background
control set of patients against which to compare a case disease.
Ideally the background would be as comprehensive as the case
histories of every person in the world; however, we are limited by
the information present in the EHR and its biases. Using two
control cohorts with different etiologies should expose most data
biases within each control by comparing each case cohort to both.
Although less than the ideal, being aware of each control group’s
biases will allow for broader and more nuanced analyses of the
case diseases.
Methods
ADAMS is an application that can compare case and control
disease cohorts within an EHR and then generate statistical
analyses that can be compared to external data sources. Based on
each case-control pairing, ADAMS can generate a list of all ICD-
9-CM codes within the case cohort along with their respective p-
values and false discovery rates (FDR). At any given FDR
threshold, ADAMS can generate a network diagram of statistically
significant ICD-9-CM codes that can be tied to other data sources.
The data sources used for this paper were:
1. The NYPH EHR ICD-9-CM coded diagnoses;
2. The NYPH EHR natural language processed discharge
summaries;
3. Article abstracts mentioning the rare diseases from the
National Center for Biotechnology Information (NCBI)
PubMed repository;
4. Wikipedia articles on the rare diseases.
Diagnosis ICD-9-CM tables
The NYPH IRB protocol for this project was marked as Non
Human Subject Research and thus was exempt from the
requirement of formal approval by the IRB. The NYPH EHR
was de-identified in accordance with HIPAA regulations, and all
data that could uniquely identify patients were removed before the
study was commenced. This limited data set comprises multiple
tables containing diagnoses, procedures, lab results, prescription
orders, and demographic information encoded using ICD-9-CM
codes [28] and proprietary medical codes. ICD-9-CM codes form
a hierarchy to describe conditions in increasingly finer granularity.
The codes are limited in expression and do not describe all
conditions. They are not always accurate indicators of medical
conditions [29,30]; but in the case of the diseases discussed in this
paper, which generally have specific, well-defined names, we
assume that the ICD-9-CM codes are accurately assigned to
patients because the code descriptions clearly contain the disease
names (Table 1). Incomplete data inherent within the EHR mean
that the number of patients from this data set provides the lower
bound for the actual number of patients at NYPH with each
disease.
Discharge summaries
In addition to the diagnosis tables, which primarily record out-
patient visits, the limited NYPH EHR also includes de-identified
in-patient discharge summaries, which were parsed for disease
associations. Discharge summaries are textual reports written by
physicians. These were processed using Medical Language
Extraction and Encoding System (MedLEE), an NLP system
[31]. The NLP reports contain disease terms found within the
discharge summaries that were coded using the National Library
of Medicine (NLM) Unified Medical Language System (UMLS)
[32]. The discharge summary data were made available at an
aggregated level. A search was done to identify the discharge
summaries that contained the UMLS codes of the diseases of
interest. After the reports were identified, all of the unique UMLS
codes across the reports were listed. The NIH NLM mappings
between ICD-9-CM and UMLS codes were used, but the
mappings were not comprehensive. Many UMLS codes are
unmapped to ICD-9-CM codes, and many ICD-9-CM codes are
unmapped to UMLS codes [33]. In order to capture the
unmapped codes, the UMLS codes were mapped to ICD-9-CM
codes using the procedure outlined in Fig. 2 so that a consistent
description language was used for medical terms. To be as
comprehensive as possible, we used the NYPH discharge
summaries recorded between 1991 and 2009. Because the
discharge summary data were at an aggregated level, it was not
possible to combine ICD-9-CM data and discharge summary data
at the patient level.
PubMed articles
The National Center for Biotechnology Information (NCBI)
PubMed resource is a centralized Internet repository of biological
and medical journal articles [9]. Data mining the site involved
collating all articles whose title or abstract mentioned our rare
diseases of interest and then searching against a list of diseases
(compiled from ICD-9-CM codes) to find co-occurrences of words.
Abstracts were chosen as the primary method of determining
associations because of time constraints precluding comprehensive
natural language processing of the full texts of journal articles.
MedLEE was used to extract disease terms from the abstracts. The
results of NLP were in the same aggregated output format as for
the discharge summary results. UMLS terms were matched to
ICD-9-CM codes with the same method used for discharge
summaries.
Wikipedia articles
Wikipedia was used as a proof of concept that can be mined for
rare disease information. Pages of case diseases were downloaded
and mined automatically using the Wikipedia application
Disease Associations in Electronic Clinical Data
PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21132programmers interface (API) [34]. We ensured that only the latest
revision of each page was downloaded and analyzed for
occurrences of ICD-9-CM code descriptions. For a Wikipedia
page to be tagged as having a given ICD-9-CM code, an exact
match of that code’s full description would have to be found in the
page’s text. Wikipedia was chosen as a source because of its
convenient API and its explicit lack of intellectual property
restrictions.
Table 1. ICD-9 codes used to retrieve the sets of patients of the three rare diseases and the two control groups from NYPH EHR
(2004–2009).
Rare disease ICD-9 codes Number of patients
Kaposi sarcoma 176, 176.0, 176.1, 176.2, 176.3, 176.4, 176.5, 176.8, 176.9 221
Toxoplasmosis 130, 130.0, 130.1, 130.2, 130.3, 130.4, 130.5, 130.7, 130.8, 130.9 138
Kawasaki disease 446.1 213
Post-traumatic stress disorder (control) 309.81 1281
Influenza (control) 487, 487.0, 487.1, 487.8 2582
doi:10.1371/journal.pone.0021132.t001
Figure 2. Outline of how search terms are mapped against ICD-9 code descriptions, using malignant lymphoma as an example.
Firstly the search term (S1) is broken down into words which are matched against the target phrase (S2) using regular expressions. Starting with every
word in S1, S1 and S2 are compared and if there is no match, words are repeatedly removed from the match expression until only one word remains.
If no match is found, a Levenshtein distance function is used to compare the terms for equality and if it scores lower that a threshold t the terms are
considered as matching.
doi:10.1371/journal.pone.0021132.g002
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ADAMS functions as a pipeline of discrete, automated stages
where each stage enriches data generated from previous stages.
The major steps involved in determining disease assocations using
our algorithm can be summarized as follows:
1. Identify diseases of interest for both case and control cohorts.
2. Identify patients with diseases of interest.
3. Load the ICD-9-CM code history of patients with diseases of
interest into each disease cohort.
4. Run ADAMS to establish statistically significant associations.
5. Search for disease association data in other data sources such as
PubMed and NLP discharge summaries.
6. Draw network diagram combining ICD-9-CM data with data
from other sources.
Patients with the diseases of interest were identified using ICD-
9-CM codes. Any patient whose medical history included any
ICD-9-CM codes that denoted a disease of interest within
calendar years 2004–2009 were included in the respective disease
cohorts. Using ICD-9-CM codes allowed for broader selection of
patients since both inpatient and outpatient records in the NYPH
EHR have ICD-9-CM codes.
Once a patient was identified as having a disease of interest, all
of that patients ICD-9-CM code data from 2004–2009 were
loaded into the respective cohort table. These ICD-9-CM lists
served as the basis for finding statistically significant positive
associations.
On the ADAMS interface (Fig. S3), the case and control cohorts
are selected. ADAMS is also able to limit time intervals for data,
but for the purposes of this paper no time limits were specified; the
entire time period of 2004–2009 was under evaluation.
Within ADAMS, the hypergeometric distribution was used to
calculate the p-value of each ICD-9-CM code in the case cohort
versus the control cohort. The cumulative distribution function
(cdf) was calculated based on the number of patients with a given
code and the total number of patients in each cohort. If a code
existed in the case cohort but not the control cohort, the control
cohort was assigned a code patient count of zero. The p-value for
each code (p) was calculated as (1 - cdf). Because the
hypergeometric cdf is asymmetrical, this test identifies positive
associations that are statistically significant; negative associations
are not identified.
To test for multiple hypotheses, we followed the bootstrapping
method described in Khiabanian et al. [35]. Bootstrapping
involved creating randomized case and control sets based on the
observed case and control cohorts. For each case and control
cohorts pairing, the case and control patients were placed into a
consolidated pool of patients. A patient was selected at random
with replacement from the pool. That patient then was assigned to
the bootstrap case group. This process was repeated until the
bootstrap case group reached the same number of patients as the
observed case group. The same process of random selection was
done for the bootstrap control group until it reached the same
number of patients as the observed control group.
Similar to the previous step, within each bootstrap data set, the
hypergeometric value for each ICD-9-CM code was calculated.
The number of p-values less than each p was counted and then
divided by the number of bootstraps. This quotient represented
the expected count of p-values less than each p. The expected
count was divided by the observed count for each p. The quotient
of expected count divided by observed count defined the false
discovery rate (FDR) per p. The FDR cutoff was set at less than
0.05. The desired number of bootstraps is entered, which for this
paper was one hundred thousand. Clicking on the ‘‘Search’’
button in ADAMS begins the process of statistical analysis.
Network diagrams
The statistical analysis described thus far applies only to the
ICD-9-CM coded data. The other three data sources (discharge
summaries, PubMed, and Wikipedia) act as references for
comparing patterns observed in the EHR with documented
findings in the literature. ADAMS combines the four data sources
to create a visual network diagram that draws links between
common associations among them. The diagram is ICD-9-CM
centric; only the intersections between ICD-9-CM-derived
associations and associations from each of the other data sources
were included. Thus any associations reported in the other sources
that were absent in the ICD-9-CM associations were not shown.
1. Each graph begins with the ICD-9-CM coded set of diseases,
C, that are associated with the disease of interest.
2. First a node for the disease of interest, D, is added to the graph.
3. For each co-occurrence Ms[ Cs, where Cs is the set of the
statistically significant co-occurrences with D and Cs(C,
create a graph node for Ms along with an edge connecting D to
Ms.
4. Each of the three ancillary data sources are then queried
separately to find the set Cx of associated co-occurrences with
D.
5. For each co-occurrence Ms[ Cs and Mx[ Cx, the terms are
compared and if a match is found between Ms and Mx, Mx is
added as a graph node and an edge between Ms and Mx is
created.
6. If the nodes and edge do not already exist, a node Sx
representing the ancillary data source that contains Mx and a
connecting edge from Mx to Sx are added.
Despite efforts such as the UMLS to unify ontologies, mapping
between different medical vocabularies is non-trivial. Each of the
four data sources has its own terminology for particular diseases, so
it is not always possible to create perfect mappings between terms.
ADAMS uses a fuzzy matching procedure to compare terms in
different data sources to reduce the number of unmatched terms
(Fig. 2). If an exact match cannot be made, partial terms are made
by repeatedly removing individual words from a term and
converting plural nouns into their singular form. These partial
terms are then matched to each other. Finally, if this fails to yield
matches, a Levenshtein distance function [36,37] is used to
calculate the number of insertions, deletions, and changes between
the terms; and if this is below a threshold t, the terms are classed as
matching.
The number of records in each data source is given in Table 2.
Adjusting granularity of network diagrams
Although network diagrams contain only statistically significant
associations, the number of nodes can still be prohibitively large.
To address this issue, custom super nodes can be defined, which
subsume existing nodes to adjust the granularity of the network.
For example, in the case of Kaposi sarcoma, multiple types of
malignant neoplasms can be collapsed into a single ‘‘malignant
neoplasms’’ super node (Fig. S1). Super nodes are defined by
keywords, against which nodes are matched. As the network is
built, each node in a link is compared to the database of super
nodes and terms. If a super node match is found, edges are
redirected to the super node. Links between super nodes can be
Disease Associations in Electronic Clinical Data
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links between super nodes when in reality the link occurs because
of a node within the category and not the category itself.
Results
For each rare disease (Kaposi sarcoma, toxoplasmosis, and
Kawasaki disease), a cohort of patients was constructed and was
compared to each of two control cohorts: one cohort of patients
with PTSD and one with influenza (Table 1). The coded data used
in the analyses covered years 2004 to 2009 since this time period
has the richest and most complete record sets in the hospital.
Discharge summary data from 1991 to 2009 were used. Relevant
PubMed and Wikipedia articles from any year of publication were
analyzed. Table 3 shows a selected list of highly statistically
significant associated medical conditions with these rare diseases
compared to either or both control cohorts. (A complete list of all
significant associations are shown in Tables S1, S2, S3, S4, S5, S6.)
Fig. 3 and Fig. S1 and S2 show the results of combining all four
data sources for determining significant disease associations
compared to influenza. (Similar diagrams obtained with PTSD
are not shown.) Associated diseases can be split into two sets: those
that confirm known relationships where the results from the
diagnoses, PubMed articles, and Wikipedia overlap, and novel
associations that occur only in the diagnoses or NLP reports.
The EHR codes associated with a case disease can be divided
into the following groups: 1) codes of well-known characteristics of
the disease; 2) codes related to well-known disease associations and
their manifestations; 3) codes of disease treatments and their
sequelae; 4) codes related to treatment of associated diseases and
their sequelae; 5) confounded, rare, or previously unreported
disease associations.
ADAMS identified a total of 303 ICD-9-CM codes associated
with Kaposi sarcoma that were statistically significant across both
PTSD and influenza control groups. Of these codes, 178 were
shared between both control groups, 82 codes were associated only
with influenza, and 43 were associated only with PTSD. A total of
88 codes were different types of specific malignant neoplasm, 19 of
which were associated only with flu, whereas only 1 was associated
only with PTSD.
The ICD-9-CM codes directly related to Kaposi sarcoma
include ‘‘176.0 Kaposi sarcoma skin,’’ ‘‘176.3 Kaposi sarcoma
gastrointestinal sites,’’ ‘‘176.4 Kaposi sarcoma lung,’’ and ‘‘280.0
Iron deficiency anemia secondary to blood loss (chronic).’’ Since
Kaposi sarcoma is strongly associated with HIV infection, many
codes related to HIV and opportunistic infections appear: ‘‘117.5
Cryptococcosis,’’ ‘‘136.3 Pneumocystosis,’’ ‘‘031.2 Disseminated
mycobacterium.’’ Liposomal anthracyclines are among the
treatments for Kaposi sarcoma [38]. One of their known side
effects is cardiotoxicity: ‘‘427.89 Other specified cardiac dysrhyth-
mias.’’ The mainstay treatment of HIV-infected individuals is
HAART. Known side effects of HAART include: ‘‘250.00
Diabetes mellitus without complication type ii or unspecified type
not stated as uncontrolled,’’ ‘‘272.4 Other and unspecified
hyperlipidemia,’’ and ‘‘357.6 Polyneuropathy due to drugs.’’
Kaposi sarcoma is also found to be associated with ‘‘282.60 Sickle-
cell disease unspecified,’’ for which there is limited describing
literature.
ADAMS identified a total of 162 ICD-9-CM codes associated with
toxoplasmosis that werestatistically significant across both PTSD and
influenza control groups. Of these codes, 86 were shared between
both control groups, 23 codes were associated only with influenza,
and53 were associated onlywith PTSD.ADAMSidentified 15codes
associated with toxoplasmosis that were statistically significant
compared to Kaposi sarcoma as the control group; and 35 codes
associated with Kaposi sarcoma that were statistically significant
compared to toxoplasmosis (Table 4 and Table S7).
The ICD-9-CM codes directly related to toxoplasmosis include
‘‘130.0 Meningoencophalitis due to toxoplasmosis,’’ ‘‘130.1
Conjunctivitis due to toxoplasmosis,’’ ‘‘130.3 Myocarditis due to
toxoplasmosis,’’ ‘‘130.4 Pneumonitis due to toxoplasmosis,’’
‘‘130.7 Toxoplasmosis of other specified sites,’’ and ‘‘130.8
Multisystemic disseminated toxoplasmosis.’’ Since toxoplasmosis
is strongly associated with HIV infection, many codes related to
HIV complications and opportunistic infections appear: ‘‘287.5
Leukocytopenia,’’ ‘‘799.4 Cachexia,’’ ‘‘112.84 Candidal esopha-
gitis,’’ ‘‘078.5 Cytomegaloviral disease.’’ Codes suggestive of
peripartum complications and congenital deformities consistent
with congenital toxoplasmosis include ‘‘130.2 Chorioretinitis due
to toxoplasmosis,’’ ‘‘646.83 Other specified antepartum compli-
cations,’’ ‘‘648.91 Other current conditions classifiable elsewhere
of mother with delivery,’’ and ‘‘655.41 Suspected damage to fetus
from other disease in the mother affecting management of mother
with delivery.’’ TMP-SMX is among the first line treatments for
toxoplasmosis, and as a sulfa drug it is known to cause exfoliative
dermatitis as an adverse drug reaction: ‘‘693.0 Dermatitis due to
drugs and medicines taken internally.’’
ADAMS identified a total of 53 ICD-9-CM codes associated
with Kawasaki disease that were statistically significant across both
PTSD and influenza control groups. Of these codes, 12 were
shared between both control groups, none were associated only
with influenza, and 41 were associated only with PTSD.
The ICD-9-CM codes directly related to Kawasaki disease
include ‘‘372.30 Conjunctivitis unspecified,’’ ‘‘414.11 Aneurysm of
coronary vessels,’’ ‘‘780.6 Fever and other physiologic disturbanc-
es of temperature regulation,’’ and ‘‘782.1 Rash and other
nonspecific skin eruption.’’ The differential diagnosis of Kawasaki
disease would include other infectious and rheumatic diseases,
such as ‘‘034.1 Scarlet fever,’’ ‘‘446.0 Polyarteritis nodosa,’’ ‘‘446.7
Takayasu’s disease,’’ ‘‘710.0 Systemic lupus erythematosus,’’ and
‘‘714.30 Chronic or unspecified polyarticular juvenile rheumatoid
arthritis.’’ Codes more likely to occur as a result of the workup for
Kawasaki diseases include ‘‘746.1 Tricuspid atresia and stenosis
congenital’’ and ‘‘746.85 Coronary artery anomaly congenital.’’ A
code that has not been described extensively is ‘‘299.00 Autistic
disorder current or active.’’
Discussion
The associations identified by ADAMS mostly describe known
characteristics of each disease, including symptoms and manifes-
tations, treatments, and possible confounders. Most interestingly,
ADAMS identified associations with limited or no reporting in the
existing literature.
Table 2. Data source sizes.
Data Source Records
EHR ICD-9-CM patients 768903
NLP records 406158
PubMed Kaposi sarcoma 1025
PubMed Kawasaki disease 598
PubMed Toxoplasmosis 960
Wikipedia One page per search term, if one exists.
doi:10.1371/journal.pone.0021132.t002
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disease in AIDS patients [39]. Although the vast majority of the
associations for Kaposi sarcoma (Tables S1 and S2) can be
explained by associations described in the literature, complications
related to neoplasms, HIV infection, risk factors for HIV infection
(sexually trasmitted infections, drug abuse), diseases associated
with HIV infection, and side effects of neoplasm treatment and
highly active antiretroviral therapy (HAART), the results showed
Kaposi sarcoma is also possibly associated with sickle cell anemia,
for which there has been limited research to confirm the links. This
relationship, however, may be a reflection of the biases in the
patient population at NYPH.
Toxoplasmosis is usually asymptomatic in immunocompetent
hosts, hence its most frequent manifestation is as an opportunistic
infection in immunocompromised hosts. Most of the ICD-9-CM
codes from the intersection of PTSD and influenza comparisons
demonstrate findings that are most consistent with HIV patients
(Tables S3 and S4), similar to Kaposi sarcoma above. The
intersection also contains codes related to complications during
the delivery of babies and to neurotoxoplasmosis, e.g., chorioret-
initis, which occurs more often in the setting of congenital infection.
The codes do not directly implicate a specific disease as the cause of
complications during pregnancy or delivery, but they do indicate
congenitalcomplications secondary to diseases of the mother, which
would be consistent with toxoplasmosis infection during pregnancy.
Because the EHR does not track relationships between patients, it
was not possible to tie the children with congenital complications to
the mothers who had complicated pregnancies or deliveries.
The ICD-9-CM codes from the comparison of toxoplasmosis to
influenza yield more psychiatric disease codes, whereas the codes
from the comparison to PTSD have more codes that can be
associated with infectious diseases in general. These findings
Table 3. A selected list of significantly associated diseases with Kaposi sarcoma, toxoplasmosis, and Kawasaki disease, determined
from the NYPH EHR, compared against either or both control groups of influenza and PTSD patients.
ICD-9 Description Odds ratio P-value FDR
Kaposi sarcoma vs. influenza and PTSD
176.0 Kaposi’s sarcoma skin N/A v0.001 v0.001
176.1 Kaposi’s sarcoma soft tissue 116.83 v0.001 v0.001
176.2 Kaposi’s sarcoma palate N/A v0.001 v0.001
Kaposi sarcoma vs. influenza only
110.3 Dermatophytosis of groin and perianal area 15.58 0.001 0.005
110.4 Dermatophytosis of foot 3.46 0.005 0.022
112.2 Candidiasis of other urogenital sites 7.79 0.005 0.023
Kaposi sarcoma vs. PTSD only
078.5 Cytomegaloviral disease 23.19 0.002 0.007
786.3 Hemoptysis 9.66 0.003 0.012
284.1 Pancytopenia 4.83 0.014 0.044
Toxoplasmosis vs. influenza and PTSD
136.3 Pneumocystosis 24.95 v0.001 v0.001
176.0 Kaposi’s sarcoma skin N/A 0.003 0.022
176.4 Kaposi’s sarcoma lung N/A 0.003 0.023
Toxoplasmosis vs. influenza only
070.32 Chronic viral hepatitis b without hepatic coma without hepatitis delta 12.47 0.001 0.011
070.54 Chronic hepatitis c without hepatic coma 3.85 0.004 0.029
054.10 Genital herpes unspecified 6.24 0.007 0.041
Toxoplasmosis vs. PTSD only
038.0 Streptococcal septicemia 13.92 0.008 0.047
038.8 Other specified septicemias 13.92 0.008 0.047
038.19 Other staphylococcal septicemia N/A 0.009 0.048
Kawasaki vs. influenza and PTSD
372.30 Conjunctivitis unspecified 3.67 v0.001 v0.001
034.1 Scarlet fever 10.39 v0.001 0.015
299.0 Autistic disorder current or active state 15.15 v0.001 0.017
Kawasaki vs. PTSD only
462 Acute pharyngitis 2.28 v0.001 0.003
446.5 Giant cell arteritis 24.06 0.002 0.020
447.8 Other specified disorders of arteries and arterioles N/A 0.003 0.034
If there are no patients with a diagnosis code in the control groups, odds ratio is not calculated (i.e. N/A). Kawasaki vs. influenza yields no significant associations not
already found in Kawasaki vs. PTSD.
doi:10.1371/journal.pone.0021132.t003
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of significant codes shows consistency in the paper’s methods; and
the codes not in the intersection illustrate the biases inherent in the
controls. The influenza control group comparison identifies codes
that exclude non-specific signs and symptoms when sick with
infectious diseases,and thePTSDcontrolgroup identifies codesthat
exclude psychiatric associations. Moreover, life-threatening diseases
qualify as traumatic events for the diagnosis of PTSD [40,41],
therefore it can be inferred that PTSD patients are more likely to
have neoplasms than influenza patients; neoplasm associations will
more likely be statistically insignificant with the PTSD cohort as the
control. Otherwise, the majority of the associations for toxoplas-
mosis can be explained by associations described in the literature,
complicationsrelatedtomasseffectsinthebrain,HIVinfection,risk
factorsforHIVinfection(sexuallytrasmittedinfections,drugabuse),
diseases associated with HIV infection, and side effects of highly
active antiretroviral therapy (HAART).
A comparison of Kaposi sarcoma with toxoplasmosis and vice
versa should then identify ICD-9-CM codes specific to each
while excluding codes related to HIV infection. This is indeed
t h ec a s e( T a b l e4a n dT a b l eS 7 ) .K a p o s is a r c o m ac o m p a r e dt o
toxoplasmosis as the control cohort shows neoplasms and other
findings specific to Kaposi sarcoma. Toxoplasmosis compared
to Kaposi sarcoma as the control cohort shows classical findings
of toxoplasmosis. Toxoplasmosis is still associated with the
disease code for HIV infection when compared to Kaposi
sarcoma. This observation is reasonable given that toxoplasmo-
sis occurs when CD4 counts fall below one hundred cells per
cubic millimeter of blood, indicating significant immunocom-
promise, whereas Kaposi sarcoma can occur in non-HIV-
infected individuals. It stands to reason that toxoplasmosis is
more dependent on severe immunocompromise in order to
manifest, hence its stronger association with HIV infection than
Kaposi sarcoma’s. [42,43].
Figure 3. The network of interactions of statistically significant diseases associated with Kawasaki disease compared to influenza
combined with results from NLP reports, PubMed articles and Wikipedia articles. Diseases linked to the diagnoses from either PubMed
(green links) or Wikipedia (blue links) are documented associations. Diseases associated purely from diagnoses (red links) or NLP reports (gold links)
are novel associations that have not been reported before.
doi:10.1371/journal.pone.0021132.g003
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statistical testing less sensitive and more specific, while choosing a
less sick cohort does the converse. A sicker control cohort would
have greater counts of patients with ICD-9-CM codes related to
that disease than a less sick cohort of the same disease. For those
codes to be statistically significant associations with the case
disease, the case cohort would have to have even larger counts of
patients with the same ICD-9-CM codes; or the control cohort
would have to be larger with the same proportion of patients with
the same ICD-9-CM codes. It then becomes necessary to choose
control cohorts carefully in order to be aware of their inherent
biases since these biases directly affect the results and guide
interpretation. Thus using multiple control cohorts whose biases
are known can provide richer results and interpretations than
using control cohorts that are created by random sampling of
patients where biases are more uncertain.
In the case of Kawasaki disease, ADAMS identified codes that
reflected the known signs and symptoms of the disease (Tables S5
and S6). The disease codes found by comparing to influenza were
a complete subset of those found by comparing to PTSD. The
codes are highly specific to Kawasaki disease and demonstrate
associations with other autoimmune diseases. The remaining
codes found by comparing to PTSD represent non-specific
findings of sickness from infectious etiology.
Among the intersection of significant ICD-9-CM codes were
scarlet fever, juvenile rheumatoid arthritis, Takayasu disease, and
systemic lupus erythematosus. Scarlet fever is part of the
differential diagnosis since both scarlet fever and Kawasaki disease
present with strawberry tongue and rash [44,45]. The others are
rheumatological diseases that can present with similar symptoms
[46–48]. Were the coded data for a longer longitudinal period, the
associations could be observed as diseases that occurred in the
same individuals later in life, thus changing the interpretation from
differential diagnosis to disease association. The statistically
significant associations with ‘‘746.1 Tricuspid atresia and stenosis
congenital’’ and ‘‘746.85 Coronary artery anomaly congenital’’
reflect bias from the workup for Kawasaki disease, which includes
echocardiography to establish a baseline for possible coronary
artery aneurysm.
Most importantly, the statistically significant association with
‘‘299.00 Autistic disorder current or active’’ state may reflect a
sequela from the systemic inflammation of Kawasaki disease that
thus far has not been well described. A case study by Tabarki et. al.
[49] suggested a possible link between Kawasaki disease and autistic
behavior for which we report a statistical evidence of an association
at NYPH, which has a much larger patient cohort. Definitive
neurological complications of Kawasaki disease have been de-
scribedbutarelimitedtotheacutesetting.Long-termcomplications
of autism as a result of Kawasaki disease or autistic individuals being
more susceptible to Kawasaki disease have not been described
extensively. There is literature on the controversy of whether autism
and Kawasaki disease are complications of vaccines [50–54]. It is
possible that the inflammatory response that underlies Kawasaki
disease may effect neurological changes that result in autism, or the
susceptibility to the underlying pathophysiology may lead to both
diseases occurring independently in the same individual. The
limitation of the current study of ADAMS does not evaluate the
time course of disease. Further study of the clinical histories of the
patients with both Kawasaki disease and autism as identified by
ADAMS merits further pursuit. With respect to the network
diagrams for Kawasaki disease, it should be noted that there are no
connections from external sources to autism despite the Tabarki
case report. The lack of connections occurred because autism was
described only in the body of the paper and not in the abstract;
natural language processing was done only on abstracts.
The NYPH EHR suffers from data biases. First, there are
multiple ways that information can be entered into the system, and
each department within the hospital can follow its own set of
guidelines for data entry. Second, NYPH mainly serves patients in
Manhattan and to a lesser extent the other four boroughs, so its
EHR is mostly representative of the population of New York City.
While we can draw conclusions of clinical interest from this
population, they may not necessarily represent disease associations
at a national or global level.
Table 4. Significantly associated diseases with toxoplasmosis, compared to Kaposi sarcoma (FDRv0.05).
ICD-9 Description Odds ratio P-value FDR
130.0 Meningoencephalitis due to toxoplasmosis 70.46 v0.001 v0.001
130.7 Toxoplasmosis of other specified sites 72.07 v0.001 v0.001
780.39 Other convulsions 5.52 v0.001 v0.001
042 Human immunodeficiency virus (hiv) disease 1.90 v0.001 v0.001
130.8 Multisystemic disseminated toxoplasmosis N/A v0.001 v0.001
323.9 Unspecified cause of encephalitis N/A v0.001 0.004
345.10 Generalized convulsive epilepsy without intractable epilepsy 16.01 v0.001 0.005
345.90 Epilepsy unspecified without intractable epilepsy 3.20 0.001 0.011
130.2 Chorioretinitis due to toxoplasmosis N/A 0.001 0.012
348.8 Other conditions of brain N/A 0.001 0.012
784.0 Headache 2.31 0.003 0.021
363.00 Focal chorioretinitis unspecified N/A 0.003 0.025
364.3 Unspecified iridocyclitis 12.81 0.003 0.025
644.10 Other threatened labor unspecified as to episode of care 12.81 0.003 0.025
648.91 Other current conditions classifiable elsewhere of mother with delivery 6.41 0.009 0.050
Table S7 shows the significantly associated diseases with Kaposi sarcoma, compared to toxoplasmosis. If there are no patients with a diagnosis code in the control
groups, odds ratio is not calculated (i.e. N/A).
doi:10.1371/journal.pone.0021132.t004
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knowledge from coded hospital records and corroborates the
findings with other data sources. Therefore, it should be noted that
there may be links between medical conditions that ADAMS
cannot identify because those conditions lack coded descriptions.
Future work will be focused on analyzing the relationships for
diseases that have no clear ICD-9-CM codes, especially using
textual reports that have undergone natural language processing.
ADAMS can be applied to the analysis of less rare diseases. It
would find more associations, since more common diseases would
have larger cohorts and thus be more likely to have different
comorbidities across all the individuals. To cope with the larger
number of associations, the FDR cutoff can be set to a lower
threshold in order to reduce the number of statistically significant
findings. Otherwise, investigators with clinical expertise will have
to spend more time analyzing the longer list to rule out
confounding. This may still be fruitful, albeit time consuming,
since there may be true associations that would be excluded by a
stricter FDR cutoff. By focusing on rare diseases in this paper, the
burden of many associations and confounding was intrinsically
limited, which made analysis and interpretation easier and more
manageable.
In conclusion, ADAMS confirms relationships between these
three rare diseases and other medical conditions that have already
been reported in PubMed or Wikipedia. This means our method is
capable of detecting signal amid the noise in the NYPH EHR with
greater confidence than simply using statistical multiple hypothesis
testing methods. In particular, the starting points for further
investigations are the results reported only in the EHR that have
not been previously described in the literature. Although ADAMS
by itself is not a diagnosis tool, we suggest that it could be further
refined into a tool for health professionals as an effective means to
confirm descriptions in existing literature and to identify under-
recognized or undiscovered associations for further clinical
inquiry.
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the ‘‘Search’’ button in ADAMS begins the process of statistical
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